|
|
|
|
|
Product Name
|
3-Nitrotyrosine antibody [11C2]
|
| |
See all 3-Nitrotyrosine antibodies (3)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Mouse monoclonal [11C2] to 3-Nitrotyrosine
|
|
Immunogen
|
Chemical / Small Molecule: Nitrotyrosine conjugated to KLH.
|
|
Reacts with
(species key)
|
N/A
|
|
Specificity
|
This antibody reacts with free and bound Nitrotyrosine.
|
|
Tested applications
(see key)
|
ELISA, ICC, IHC-P, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions ELISA: 1/100 - 1/1000. ICC: 1/100 - 1/500. IHC-P: 1/250 (PMID 19541933). WB: 1/100 - 1/500. Predicted molecular weight: 1 kDa.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cell Biology >> Other Antibodies >> Oxidative Stress Signal Transduction >> Metabolism >> Amino Acids
|
|
Relevance
|
Protein tyrosine nitration results in a post-translational modification that is increasingly receiving attention as an important component of nitric oxide signaling. While multiple nonenzymatic mechanisms are known to be capable of producing nitrated tyrosine residues, most tyrosine nitration events involve catalysis by metalloproteins such as myeloperoxidase, eosinophilperoxidase, myoglobin, the cytochrome P-450s, superoxide dismutase and prostacyclin synthase. Various studies have shown that protein tyrosinenitration is limited to specific proteins and that the process is selective. For example, exposure of human surfactant protein A, SP-A, to oxygen-nitrogen intermediates generated by activated alveolar macrophages resulted in specific nitration of SP-A at tyrosines 164 and 166, while addition of 1.2 mMCO 2 resulted in additional nitration at tyrosine 161. The presence of nitrotyrosine-containing proteins has shown high correlation to disease states such as atherosclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.
|
|
|
3-Nitrotyrosine antibody [11C2] (ab53232)
|
|
Raised in
|
Mouse
|
|
Clonality
|
Monoclonal
|
|
Clone number
|
11C2
|
|
Isotype
|
IgG1
|
|
Light chain type
|
kappa
|
|
Purity
|
Tissue culture supernatant
|
|
Storage buffer
|
Preservative: 0.02% Sodium Azide Constituents: Tissue culture supernatant Material safety datasheet (MSDS) for this product: Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
Concentration not determined - why is this?
|
|
Storage instructions
|
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this 3-Nitrotyrosine antibody [11C2] is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
References for 3-Nitrotyrosine antibody [11C2] (ab53232)
|
|
This product has been used in: (two most recent references)
McGrath-Morrow S et al. Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 296:L565-73 (2009). PubMed: 19151108
Podowski M et al. Complex integration of matrix, oxidative stress, and apoptosis in genetic emphysema. Am J Pathol 175:84-96 (2009). IHC-P. PubMed: 19541933
See all 3 publication references for this product.
If you publish research using ab53232 please let us know so that we can cite the reference on this datasheet.
|
| |
|
Search PubMed (MEDLINE) for references to 3-Nitrotyrosine
|
| |
3-Nitrotyrosine antibody [11C2] - more information
|
Customer reviews (feedback) regarding 3-Nitrotyrosine antibody [11C2] |
Customer FAQs regarding 3-Nitrotyrosine antibody [11C2] |
Protocols for 3-Nitrotyrosine antibody [11C2] |
Price and availability of products related to 3-Nitrotyrosine antibody [11C2] |
| |
3-Nitrotyrosine antibody [11C2] - related products:
|
|
|
| |
3-Nitrotyrosine antibody [11C2] - other tools:
|
Contact Abcam with a Technical Enquiry about 3-Nitrotyrosine antibody [11C2] |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"